{
  "retracted": false,
  "timestamp": 1580515200000,
  "updates": [
    {
      "timestamp": 1588668026324,
      "identifier": {
        "doi": "10.1016/j.ygyno.2019.12.007"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.ygyno.2019.02.008"
  },
  "journal": "Gynecologic Oncology",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444]"
}
